Patent · US Active

Immunoassays for differential detection of clostridium difficile

US11434264B2 · kind B2 · utility

5Cited by
10References
30Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 12, 2016
Grant dateSep 6, 2022
Priority date
Expiry dateFeb 12, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/33
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Ultrasensitive and quantitative assays for detecting toxins of Clostridium difficile, which may involve digital ELISA, are provided. Also provided herein are differential detection assays that allow for distinguishing toxin B of highly virulent Clostridium difficile strains from toxin B of less virulent strains.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.